An opt-OUT buyback seems pretty forceful, but it's only 1% of the market cap. That 1% make up 50% of the names on the register. Pretty surprising stats.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025